International Survey Reveals Critical Gaps in Cardio-Oncology Training Despite Rising Clinical Demand

An international survey presented at ESC Cardio-Oncology 2026 has identified substantial deficiencies in cardio-oncology training across multiple healthcare systems. The…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Genomic instability fuels cancer resistance through newly identified cellular pathway

New research reveals how genomic instability in ovarian cancer activates the STING-WNT pathway, creating protective myofibroblasts that drive both immune…

UK Nursing Regulator Failed to Screen Criminal Records for 12 Years

The UK's nursing regulator admits to 12 years of systematic failures in reviewing criminal records for healthcare professionals. More than…

Zanidatamab Plus Chemotherapy Shows 56% Improvement in HER2+ Gastric Cancer

Zanidatamab plus chemotherapy reduced disease progression risk by 44% compared to trastuzumab in HER2-positive gastroesophageal cancer patients. The phase III…

New PET Tracer Successfully Detects Alpha-Synuclein in Living Brains for Parkinson’s Diagnosis

Revolutionary PET tracer [11C]MODAG-005 successfully detects alpha-synuclein protein aggregates in living brains, offering breakthrough potential for early Parkinson's disease diagnosis…

Heart patch therapy shows promise for repairing damaged cardiac tissue

New editorial in NEJM explores cardiac patch therapy as a revolutionary approach to heart repair. These innovative treatments could restore…

Stem Cell Heart Patch Shows Promise in Advanced Heart Failure Trial

A stem cell-engineered heart patch improved cardiac function by 25% in patients with advanced heart failure during a first-in-human trial.…

Experimental GSK drug achieves functional hepatitis B cure in 1 in 5 patients

GSK's experimental drug bepirovirsen achieved functional hepatitis B cure in 18% of patients during phase 2 trials, vastly outperforming current…

Trump Drug Pricing Deals Face First Test as New Medications Launch

President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test as new medications launch. Healthcare…

GMJ BriefsView all →